These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24773329)

  • 1. Collaborative DTM reduces hospitalization and healthcare costs in patients with diabetes treated with polypharmacy.
    Brophy L; Williams A; Berman EJ; Keleti D; Michael KE; Shepherd M; Fox SA; Jacobs C; Tan-Torres S; Gelzer AD; Tegenu M
    Am J Manag Care; 2014 Mar; 20(3):e72-81. PubMed ID: 24773329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of a comprehensive pharmacist medication-therapy management service.
    Shaya FT; Chirikov VV; Rochester C; Zaghab RW; Kucharski KC
    J Med Econ; 2015; 18(10):828-37. PubMed ID: 25985395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Best practices: improving patient outcomes and costs in an ACO through comprehensive medication therapy management.
    Brummel A; Lustig A; Westrich K; Evans MA; Plank GS; Penso J; Dubois RW
    J Manag Care Spec Pharm; 2014 Dec; 20(12):1152-8. PubMed ID: 25597053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the North Carolina long-term care polypharmacy initiative: a multiple-cohort approach using propensity-score matching for both evaluation and targeting.
    Trygstad TK; Christensen DB; Wegner SE; Sullivan R; Garmise JM
    Clin Ther; 2009 Sep; 31(9):2018-37. PubMed ID: 19843492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a pharmacist-managed hypertension program on health system costs: an evaluation of the Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN).
    Houle SK; Chuck AW; McAlister FA; Tsuyuki RT
    Pharmacotherapy; 2012 Jun; 32(6):527-37. PubMed ID: 22552863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health care expenditures and therapeutic outcomes of a pharmacist-managed anticoagulation service versus usual medical care.
    Hall D; Buchanan J; Helms B; Eberts M; Mark S; Manolis C; Peele P; Docimo A
    Pharmacotherapy; 2011 Jul; 31(7):686-94. PubMed ID: 21923456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of two different models of anticoagulation management services with usual medical care.
    Rudd KM; Dier JG
    Pharmacotherapy; 2010 Apr; 30(4):330-8. PubMed ID: 20334453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reductions in Medication-Related Hospitalizations in Older Adults with Medication Management by Hospital and Community Pharmacists: A Quasi-Experimental Study.
    Pellegrin KL; Krenk L; Oakes SJ; Ciarleglio A; Lynn J; McInnis T; Bairos AW; Gomez L; McCrary MB; Hanlon AL; Miyamura J
    J Am Geriatr Soc; 2017 Jan; 65(1):212-219. PubMed ID: 27714762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of pharmacist consultations provided to patients with diabetes on healthcare costs in a health maintenance organization.
    Gerber RA; Liu G; McCombs JS
    Am J Manag Care; 1998 Jul; 4(7):991-1000. PubMed ID: 10181997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individualized medication assessment and planning: optimizing medication use in older adults in the primary care setting.
    Roth MT; Ivey JL; Esserman DA; Crisp G; Kurz J; Weinberger M
    Pharmacotherapy; 2013 Aug; 33(8):787-97. PubMed ID: 23722438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacist response to alerts generated from Medicaid pharmacy claims in a long-term care setting: results from the North Carolina polypharmacy initiative.
    Trygstad TK; Christensen D; Garmise J; Sullivan R; Wegner S
    J Manag Care Pharm; 2005 Sep; 11(7):575-83. PubMed ID: 16137215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive health management pharmacist-delivered model: impact on healthcare utilization and costs.
    Moczygemba LR; Alshehri AM; Harlow LD; Lawson KA; Antoon DA; McDaniel SM; Matzke GR
    Am J Manag Care; 2019 Nov; 25(11):554-560. PubMed ID: 31747234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can a disease self-management program reduce health care costs? The case of older women with heart disease.
    Wheeler JR; Janz NK; Dodge JA
    Med Care; 2003 Jun; 41(6):706-15. PubMed ID: 12773836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of collaborative clinician visits on postdischarge total cost of care in a polypharmacy population.
    Herges JR; Borah BJ; Moriarty JP; Garrison GM; Gullerud RE; Angstman KB
    Am J Health Syst Pharm; 2020 Oct; 77(22):1859-1865. PubMed ID: 33124654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Burden of Narcolepsy Disease (BOND) study: health-care utilization and cost findings.
    Black J; Reaven NL; Funk SE; McGaughey K; Ohayon M; Guilleminault C; Ruoff C; Mignot E
    Sleep Med; 2014 May; 15(5):522-9. PubMed ID: 24768358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced Practice Pharmacists: a retrospective evaluation of the efficacy and cost of ClinicaL Pharmacist PractitionErs managing ambulatory Medicare patients in North Carolina (APPLE-NC).
    Kislan MM; Bernstein AT; Fearrington LR; Ives TJ
    BMC Health Serv Res; 2016 Oct; 16(1):607. PubMed ID: 27769219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing medication use with a pharmacist-provided comprehensive medication management service for patients with psychiatric disorders.
    Cobb CD
    Pharmacotherapy; 2014 Dec; 34(12):1336-40. PubMed ID: 25329409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic outcomes of pharmacist-physician medication therapy management for polypharmacy elderly: A prospective, randomized, controlled trial.
    Lin HW; Lin CH; Chang CK; Chou CY; Yu IW; Lin CC; Li TC; Li CI; Hsieh YW
    J Formos Med Assoc; 2018 Mar; 117(3):235-243. PubMed ID: 28549592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and economic outcomes of the Cincinnati Pharmacy Coaching Program for diabetes and hypertension.
    Wertz D; Hou L; DeVries A; Dupclay L; McGowan F; Malinowski B; Cziraky MJ
    Manag Care; 2012 Mar; 21(3):44-54. PubMed ID: 22471165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparisons of rosiglitazone versus pioglitazone monotherapy introduction and associated health care utilization in Medicaid-enrolled patients with type 2 diabetes mellitus.
    Balkrishnan R; Arondekar BV; Camacho FT; Shenolikar RA; Horblyuk R; Anderson RT
    Clin Ther; 2007 Jun; 29(6 Pt 1):1306-15. PubMed ID: 18036392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.